Promotion The landscape of evidence was significantly shaped by the large-scale REDUCE-IT trial, which used a high-purity ethyl ester form of omega-3. Navigating the relationship between fish oil and atrial fibrillation (afib) requires a look at both the promise and the reality of omega-3 fatty acids.
AFib Patients Fish Oil Recommendation: Choosing the Right Supplement for Heart Health
The molecular form—whether it's a triglyceride or an ethyl ester—significantly impacts absorption and efficacy. Triglyceride-form fish oil, which mirrors the natural state found in fish, is often cited as being more bioavailable and potentially safer regarding arrhythmia risk.
For the patient with afib, choosing a high-quality triglyceride-form supplement may be a safer bet than relying on the cheaper, purified ethyl ester versions used in some studies. OMEMI, however, suggested that high-dose omega-3 might actually reduce the recurrence of afib after cardiac surgery, indicating that the context—primary prevention versus secondary prevention post-procedure—is crucial.
Fish Oil Recommendation for AFib Patients: Choosing the Right Supplement
Conversely, the subsequent VITAL Rhythm trial and the newer OMEMI trial presented a more nuanced picture. Balancing Risks and Benefits in the AFib Patient Not all fish oil supplements are created equal, and this fact is central to the debate.
More About Fish oil and afib
Looking at Fish oil and afib from another angle can help expand the discussion and give readers a second clear paragraph under the same section.
More perspective on Fish oil and afib can make the topic easier to follow by connecting earlier points with a few simple takeaways.
